Amyris: Business Overview, Financials & Competitive Analysis
Amyris is a biotech company that creates chemical products using advanced fermentation processes derived from sugarcane. By early 2026 operates as a private, technology-driven provider of sustainable ingredients for f...
Cyborg Score thesis
Disciplined B2B biotech play leveraging fermentation IP for specialty ingredients with near-term scaling catalysts in emerging...
Read the full analyst-debate transcript →Get the Latest Amyris Report
Up-to-date AI-powered research, analyst debate audio & saved-company playlists
Get Current Report FreeAmyris Overview
Pro stress-test →Amyris is a biotech company that creates chemical products using advanced fermentation processes derived from sugarcane. By early 2026 operates as a private, technology-driven provider of sustainable ingredients for flavors, fragrances and cosmetics.
Strategic Profile
Pro stress-test →Following Chapter 11 in 2024, the firm refocused and divested retail brands. The company is refocusing its strategy on its core B2B ingredients business and aims to leverage its 'Lab-to-Market™' platform for sustainable ingredient manufacturing.
Competitive Landscape
Pro stress-test →Amyris competes in the specialty biochemical ingredients market against integrated chemical companies and synthetic biology firms. Key competition comes from established specialty chemical manufacturers with existing customer relationships and distribution networks, as well as other precision fermentation platforms pursuing similar ingredient applications.
Industry Context
Amyris operates in Biotechnology.
Key facts
Founded: 2003 · Headquarters: Emeryville, US · Employees: 987 · Revenue: Estimated based on 2025 growth trajectory; private company post-bankruptcy